Jin Yao Pharmaceutical: Subsidiary's Pediatric Compound Amino Acid Injection Obtains Drug Registration Certificate in Myanmar

Jin Pharma announced that its subsidiary, Jin Pharma Peace Pharmaceutical Co., Ltd., has recently received a drug registration certificate from the Ministry of Health of Myanmar for its pediatric compound amino acid injection, allowing it to be produced and sold in Myanmar. This medication is a parenteral nutrition prescription drug and the registration application was submitted to Myanmar in 2023. The domestic sales revenue of this drug in 20ml for the years 2024 and 2025 is expected to be 206 million yuan and 146 million yuan, respectively. This approval strengthens the company's foundation for expanding into overseas markets, but the uncertainty of drug sales abroad reminds investors to be cautious of risks.